カテゴリー： LP Information, 世界, 部品/材料

世界のソタグリフロジン市場予測 2023年-2029年

◆英語タイトル：Global Sotagliflozin Market Growth 2023-2029
	◆商品コード：LP23JU3115 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：102 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のソタグリフロジン市場」は、過去の販売実績から2022年の世界のソタグリフロジンの総販売量を検討し、2023年から2029年の予測されるソタグリフロジンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のソタグリフロジンの市場規模を掲載し、XXX百万米ドル規模の世界のソタグリフロジン市場の詳細な分析を提供します。本インサイトレポートは、世界のソタグリフロジン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のソタグリフロジン市場における各社の独自のポジションをより深く理解するために、ソタグリフロジン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のソタグリフロジン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ソタグリフロジンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ソタグリフロジンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ソタグリフロジンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ソタグリフロジンの世界主要メーカーとしては、TargetMol、 Clearsynth、 Taiclone Biotech、 MedKoo Biosciences、 AbMole BioScience、 CSN Pharm、 Medchemexpress、 Selleck Chemical、 Viatris、 Sanofi、 Mankind Pharma、 Huikang Boyuan Chemical、 Vcare Pharmatech、 Prisun Pharmatechなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のソタグリフロジン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではソタグリフロジン市場をセグメンテーションし、種類別 (純度≧98%、純度≧99%)、用途別 (研究機関、製薬、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度≧98%、純度≧99%

・用途別区分：研究機関、製薬、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のソタグリフロジン市場の10年間の市場状況・展望は？
・世界および地域別に見たソタグリフロジン市場成長の要因は何か？
・ソタグリフロジンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ソタグリフロジンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ソタグリフロジンの年間販売量2018-2029、地域別現状・将来分析
・ソタグリフロジンの種類別セグメント：純度≧98%、純度≧99%
・ソタグリフロジンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ソタグリフロジンの用途別セグメント：研究機関、製薬、その他
・ソタグリフロジンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のソタグリフロジン市場
・企業別のグローバルソタグリフロジン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のソタグリフロジンの年間売上：2018-2023年の売上、市場シェア
・企業別のソタグリフロジン販売価格
・主要企業のソタグリフロジン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ソタグリフロジンの地域別レビュー
・地域別のソタグリフロジン市場規模2018-2023：年間販売量、売上
・主要国別のソタグリフロジン市場規模2018-2023：年間販売量、売上
・南北アメリカのソタグリフロジン販売の成長
・アジア太平洋のソタグリフロジン販売の成長
・ヨーロッパのソタグリフロジン販売の成長
・中東・アフリカのソタグリフロジン販売の成長

南北アメリカ市場
・南北アメリカの国別のソタグリフロジン販売量、売上（2018-2023）
・南北アメリカのソタグリフロジンの種類別販売量
・南北アメリカのソタグリフロジンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のソタグリフロジン販売量、売上（2018-2023）
・アジア太平洋のソタグリフロジンの種類別販売量
・アジア太平洋のソタグリフロジンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のソタグリフロジン販売量、売上（2018-2023）
・ヨーロッパのソタグリフロジンの種類別販売量
・ヨーロッパのソタグリフロジンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のソタグリフロジン販売量、売上（2018-2023）
・中東・アフリカのソタグリフロジンの種類別販売量
・中東・アフリカのソタグリフロジンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ソタグリフロジンの製造コスト構造分析
・ソタグリフロジンの製造プロセス分析
・ソタグリフロジンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ソタグリフロジンの主要なグローバル販売業者
・ソタグリフロジンの主要なグローバル顧客

地域別のソタグリフロジン市場予測レビュー
・地域別のソタグリフロジン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ソタグリフロジンの種類別市場規模予測
・ソタグリフロジンの用途別市場規模予測

主要企業分析
TargetMol、 Clearsynth、 Taiclone Biotech、 MedKoo Biosciences、 AbMole BioScience、 CSN Pharm、 Medchemexpress、 Selleck Chemical、 Viatris、 Sanofi、 Mankind Pharma、 Huikang Boyuan Chemical、 Vcare Pharmatech、 Prisun Pharmatech
・企業情報
・ソタグリフロジン製品
・ソタグリフロジン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Sotagliflozin, also known as LX4211, is an orally active and a dual SGLT1/SGLT2 inhibitor, which improves glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.
LPI (LP Information)’ newest research report, the “Sotagliflozin Industry Forecast” looks at past sales and reviews total world Sotagliflozin sales in 2022, providing a comprehensive analysis by region and market sector of projected Sotagliflozin sales for 2023 through 2029. With Sotagliflozin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sotagliflozin industry.
This Insight Report provides a comprehensive analysis of the global Sotagliflozin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sotagliflozin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sotagliflozin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sotagliflozin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sotagliflozin.
The global Sotagliflozin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sotagliflozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sotagliflozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sotagliflozin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sotagliflozin players cover TargetMol, Clearsynth, Taiclone Biotech, MedKoo Biosciences, AbMole BioScience, CSN Pharm, Medchemexpress, Selleck Chemical and Viatris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Sotagliflozin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ≥ 98 %
Purity ≥ 99 %
Segmentation by application
Research Institute
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
TargetMol
Clearsynth
Taiclone Biotech
MedKoo Biosciences
AbMole BioScience
CSN Pharm
Medchemexpress
Selleck Chemical
Viatris
Sanofi
Mankind Pharma
Huikang Boyuan Chemical
Vcare Pharmatech
Prisun Pharmatech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sotagliflozin market?
What factors are driving Sotagliflozin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sotagliflozin market opportunities vary by end market size?
How does Sotagliflozin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sotagliflozin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Sotagliflozin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Sotagliflozin by Country/Region, 2018, 2022 & 2029
2.2 Sotagliflozin Segment by Type
2.2.1 Purity ≥ 98 %
2.2.2 Purity ≥ 99 %
2.3 Sotagliflozin Sales by Type
2.3.1 Global Sotagliflozin Sales Market Share by Type (2018-2023)
2.3.2 Global Sotagliflozin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Sotagliflozin Sale Price by Type (2018-2023)
2.4 Sotagliflozin Segment by Application
2.4.1 Research Institute
2.4.2 Pharmaceutical
2.4.3 Others
2.5 Sotagliflozin Sales by Application
2.5.1 Global Sotagliflozin Sale Market Share by Application (2018-2023)
2.5.2 Global Sotagliflozin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Sotagliflozin Sale Price by Application (2018-2023)
3 Global Sotagliflozin by Company
3.1 Global Sotagliflozin Breakdown Data by Company
3.1.1 Global Sotagliflozin Annual Sales by Company (2018-2023)
3.1.2 Global Sotagliflozin Sales Market Share by Company (2018-2023)
3.2 Global Sotagliflozin Annual Revenue by Company (2018-2023)
3.2.1 Global Sotagliflozin Revenue by Company (2018-2023)
3.2.2 Global Sotagliflozin Revenue Market Share by Company (2018-2023)
3.3 Global Sotagliflozin Sale Price by Company
3.4 Key Manufacturers Sotagliflozin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sotagliflozin Product Location Distribution
3.4.2 Players Sotagliflozin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sotagliflozin by Geographic Region
4.1 World Historic Sotagliflozin Market Size by Geographic Region (2018-2023)
4.1.1 Global Sotagliflozin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Sotagliflozin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Sotagliflozin Market Size by Country/Region (2018-2023)
4.2.1 Global Sotagliflozin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Sotagliflozin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Sotagliflozin Sales Growth
4.4 APAC Sotagliflozin Sales Growth
4.5 Europe Sotagliflozin Sales Growth
4.6 Middle East & Africa Sotagliflozin Sales Growth
5 Americas
5.1 Americas Sotagliflozin Sales by Country
5.1.1 Americas Sotagliflozin Sales by Country (2018-2023)
5.1.2 Americas Sotagliflozin Revenue by Country (2018-2023)
5.2 Americas Sotagliflozin Sales by Type
5.3 Americas Sotagliflozin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sotagliflozin Sales by Region
6.1.1 APAC Sotagliflozin Sales by Region (2018-2023)
6.1.2 APAC Sotagliflozin Revenue by Region (2018-2023)
6.2 APAC Sotagliflozin Sales by Type
6.3 APAC Sotagliflozin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sotagliflozin by Country
7.1.1 Europe Sotagliflozin Sales by Country (2018-2023)
7.1.2 Europe Sotagliflozin Revenue by Country (2018-2023)
7.2 Europe Sotagliflozin Sales by Type
7.3 Europe Sotagliflozin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sotagliflozin by Country
8.1.1 Middle East & Africa Sotagliflozin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Sotagliflozin Revenue by Country (2018-2023)
8.2 Middle East & Africa Sotagliflozin Sales by Type
8.3 Middle East & Africa Sotagliflozin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sotagliflozin
10.3 Manufacturing Process Analysis of Sotagliflozin
10.4 Industry Chain Structure of Sotagliflozin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sotagliflozin Distributors
11.3 Sotagliflozin Customer
12 World Forecast Review for Sotagliflozin by Geographic Region
12.1 Global Sotagliflozin Market Size Forecast by Region
12.1.1 Global Sotagliflozin Forecast by Region (2024-2029)
12.1.2 Global Sotagliflozin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sotagliflozin Forecast by Type
12.7 Global Sotagliflozin Forecast by Application
13 Key Players Analysis
13.1 TargetMol
13.1.1 TargetMol Company Information
13.1.2 TargetMol Sotagliflozin Product Portfolios and Specifications
13.1.3 TargetMol Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 TargetMol Main Business Overview
13.1.5 TargetMol Latest Developments
13.2 Clearsynth
13.2.1 Clearsynth Company Information
13.2.2 Clearsynth Sotagliflozin Product Portfolios and Specifications
13.2.3 Clearsynth Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Clearsynth Main Business Overview
13.2.5 Clearsynth Latest Developments
13.3 Taiclone Biotech
13.3.1 Taiclone Biotech Company Information
13.3.2 Taiclone Biotech Sotagliflozin Product Portfolios and Specifications
13.3.3 Taiclone Biotech Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Taiclone Biotech Main Business Overview
13.3.5 Taiclone Biotech Latest Developments
13.4 MedKoo Biosciences
13.4.1 MedKoo Biosciences Company Information
13.4.2 MedKoo Biosciences Sotagliflozin Product Portfolios and Specifications
13.4.3 MedKoo Biosciences Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MedKoo Biosciences Main Business Overview
13.4.5 MedKoo Biosciences Latest Developments
13.5 AbMole BioScience
13.5.1 AbMole BioScience Company Information
13.5.2 AbMole BioScience Sotagliflozin Product Portfolios and Specifications
13.5.3 AbMole BioScience Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AbMole BioScience Main Business Overview
13.5.5 AbMole BioScience Latest Developments
13.6 CSN Pharm
13.6.1 CSN Pharm Company Information
13.6.2 CSN Pharm Sotagliflozin Product Portfolios and Specifications
13.6.3 CSN Pharm Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CSN Pharm Main Business Overview
13.6.5 CSN Pharm Latest Developments
13.7 Medchemexpress
13.7.1 Medchemexpress Company Information
13.7.2 Medchemexpress Sotagliflozin Product Portfolios and Specifications
13.7.3 Medchemexpress Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Medchemexpress Main Business Overview
13.7.5 Medchemexpress Latest Developments
13.8 Selleck Chemical
13.8.1 Selleck Chemical Company Information
13.8.2 Selleck Chemical Sotagliflozin Product Portfolios and Specifications
13.8.3 Selleck Chemical Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Selleck Chemical Main Business Overview
13.8.5 Selleck Chemical Latest Developments
13.9 Viatris
13.9.1 Viatris Company Information
13.9.2 Viatris Sotagliflozin Product Portfolios and Specifications
13.9.3 Viatris Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Viatris Main Business Overview
13.9.5 Viatris Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Sotagliflozin Product Portfolios and Specifications
13.10.3 Sanofi Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Mankind Pharma
13.11.1 Mankind Pharma Company Information
13.11.2 Mankind Pharma Sotagliflozin Product Portfolios and Specifications
13.11.3 Mankind Pharma Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Mankind Pharma Main Business Overview
13.11.5 Mankind Pharma Latest Developments
13.12 Huikang Boyuan Chemical
13.12.1 Huikang Boyuan Chemical Company Information
13.12.2 Huikang Boyuan Chemical Sotagliflozin Product Portfolios and Specifications
13.12.3 Huikang Boyuan Chemical Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Huikang Boyuan Chemical Main Business Overview
13.12.5 Huikang Boyuan Chemical Latest Developments
13.13 Vcare Pharmatech
13.13.1 Vcare Pharmatech Company Information
13.13.2 Vcare Pharmatech Sotagliflozin Product Portfolios and Specifications
13.13.3 Vcare Pharmatech Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Vcare Pharmatech Main Business Overview
13.13.5 Vcare Pharmatech Latest Developments
13.14 Prisun Pharmatech
13.14.1 Prisun Pharmatech Company Information
13.14.2 Prisun Pharmatech Sotagliflozin Product Portfolios and Specifications
13.14.3 Prisun Pharmatech Sotagliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Prisun Pharmatech Main Business Overview
13.14.5 Prisun Pharmatech Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Sotagliflozin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Sotagliflozin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ≥ 98 %
Table 4. Major Players of Purity ≥ 99 %
Table 5. Global Sotagliflozin Sales by Type (2018-2023) & (Tons)
Table 6. Global Sotagliflozin Sales Market Share by Type (2018-2023)
Table 7. Global Sotagliflozin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Sotagliflozin Revenue Market Share by Type (2018-2023)
Table 9. Global Sotagliflozin Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Sotagliflozin Sales by Application (2018-2023) & (Tons)
Table 11. Global Sotagliflozin Sales Market Share by Application (2018-2023)
Table 12. Global Sotagliflozin Revenue by Application (2018-2023)
Table 13. Global Sotagliflozin Revenue Market Share by Application (2018-2023)
Table 14. Global Sotagliflozin Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Sotagliflozin Sales by Company (2018-2023) & (Tons)
Table 16. Global Sotagliflozin Sales Market Share by Company (2018-2023)
Table 17. Global Sotagliflozin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Sotagliflozin Revenue Market Share by Company (2018-2023)
Table 19. Global Sotagliflozin Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Sotagliflozin Producing Area Distribution and Sales Area
Table 21. Players Sotagliflozin Products Offered
Table 22. Sotagliflozin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sotagliflozin Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Sotagliflozin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Sotagliflozin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Sotagliflozin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Sotagliflozin Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Sotagliflozin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Sotagliflozin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Sotagliflozin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Sotagliflozin Sales by Country (2018-2023) & (Tons)
Table 34. Americas Sotagliflozin Sales Market Share by Country (2018-2023)
Table 35. Americas Sotagliflozin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Sotagliflozin Revenue Market Share by Country (2018-2023)
Table 37. Americas Sotagliflozin Sales by Type (2018-2023) & (Tons)
Table 38. Americas Sotagliflozin Sales by Application (2018-2023) & (Tons)
Table 39. APAC Sotagliflozin Sales by Region (2018-2023) & (Tons)
Table 40. APAC Sotagliflozin Sales Market Share by Region (2018-2023)
Table 41. APAC Sotagliflozin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Sotagliflozin Revenue Market Share by Region (2018-2023)
Table 43. APAC Sotagliflozin Sales by Type (2018-2023) & (Tons)
Table 44. APAC Sotagliflozin Sales by Application (2018-2023) & (Tons)
Table 45. Europe Sotagliflozin Sales by Country (2018-2023) & (Tons)
Table 46. Europe Sotagliflozin Sales Market Share by Country (2018-2023)
Table 47. Europe Sotagliflozin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Sotagliflozin Revenue Market Share by Country (2018-2023)
Table 49. Europe Sotagliflozin Sales by Type (2018-2023) & (Tons)
Table 50. Europe Sotagliflozin Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Sotagliflozin Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Sotagliflozin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Sotagliflozin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Sotagliflozin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Sotagliflozin Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Sotagliflozin Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Sotagliflozin
Table 58. Key Market Challenges & Risks of Sotagliflozin
Table 59. Key Industry Trends of Sotagliflozin
Table 60. Sotagliflozin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Sotagliflozin Distributors List
Table 63. Sotagliflozin Customer List
Table 64. Global Sotagliflozin Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Sotagliflozin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Sotagliflozin Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Sotagliflozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Sotagliflozin Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Sotagliflozin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Sotagliflozin Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Sotagliflozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Sotagliflozin Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Sotagliflozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Sotagliflozin Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Sotagliflozin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Sotagliflozin Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Sotagliflozin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. TargetMol Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 79. TargetMol Sotagliflozin Product Portfolios and Specifications
Table 80. TargetMol Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. TargetMol Main Business
Table 82. TargetMol Latest Developments
Table 83. Clearsynth Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 84. Clearsynth Sotagliflozin Product Portfolios and Specifications
Table 85. Clearsynth Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Clearsynth Main Business
Table 87. Clearsynth Latest Developments
Table 88. Taiclone Biotech Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 89. Taiclone Biotech Sotagliflozin Product Portfolios and Specifications
Table 90. Taiclone Biotech Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Taiclone Biotech Main Business
Table 92. Taiclone Biotech Latest Developments
Table 93. MedKoo Biosciences Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 94. MedKoo Biosciences Sotagliflozin Product Portfolios and Specifications
Table 95. MedKoo Biosciences Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. MedKoo Biosciences Main Business
Table 97. MedKoo Biosciences Latest Developments
Table 98. AbMole BioScience Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 99. AbMole BioScience Sotagliflozin Product Portfolios and Specifications
Table 100. AbMole BioScience Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. AbMole BioScience Main Business
Table 102. AbMole BioScience Latest Developments
Table 103. CSN Pharm Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 104. CSN Pharm Sotagliflozin Product Portfolios and Specifications
Table 105. CSN Pharm Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. CSN Pharm Main Business
Table 107. CSN Pharm Latest Developments
Table 108. Medchemexpress Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 109. Medchemexpress Sotagliflozin Product Portfolios and Specifications
Table 110. Medchemexpress Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Medchemexpress Main Business
Table 112. Medchemexpress Latest Developments
Table 113. Selleck Chemical Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 114. Selleck Chemical Sotagliflozin Product Portfolios and Specifications
Table 115. Selleck Chemical Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Selleck Chemical Main Business
Table 117. Selleck Chemical Latest Developments
Table 118. Viatris Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 119. Viatris Sotagliflozin Product Portfolios and Specifications
Table 120. Viatris Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Viatris Main Business
Table 122. Viatris Latest Developments
Table 123. Sanofi Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Sotagliflozin Product Portfolios and Specifications
Table 125. Sanofi Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
Table 128. Mankind Pharma Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 129. Mankind Pharma Sotagliflozin Product Portfolios and Specifications
Table 130. Mankind Pharma Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Mankind Pharma Main Business
Table 132. Mankind Pharma Latest Developments
Table 133. Huikang Boyuan Chemical Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 134. Huikang Boyuan Chemical Sotagliflozin Product Portfolios and Specifications
Table 135. Huikang Boyuan Chemical Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Huikang Boyuan Chemical Main Business
Table 137. Huikang Boyuan Chemical Latest Developments
Table 138. Vcare Pharmatech Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 139. Vcare Pharmatech Sotagliflozin Product Portfolios and Specifications
Table 140. Vcare Pharmatech Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Vcare Pharmatech Main Business
Table 142. Vcare Pharmatech Latest Developments
Table 143. Prisun Pharmatech Basic Information, Sotagliflozin Manufacturing Base, Sales Area and Its Competitors
Table 144. Prisun Pharmatech Sotagliflozin Product Portfolios and Specifications
Table 145. Prisun Pharmatech Sotagliflozin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Prisun Pharmatech Main Business
Table 147. Prisun Pharmatech Latest Developments
List of Figures
Figure 1. Picture of Sotagliflozin
Figure 2. Sotagliflozin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sotagliflozin Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Sotagliflozin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Sotagliflozin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ≥ 98 %
Figure 10. Product Picture of Purity ≥ 99 %
Figure 11. Global Sotagliflozin Sales Market Share by Type in 2022
Figure 12. Global Sotagliflozin Revenue Market Share by Type (2018-2023)
Figure 13. Sotagliflozin Consumed in Research Institute
Figure 14. Global Sotagliflozin Market: Research Institute (2018-2023) & (Tons)
Figure 15. Sotagliflozin Consumed in Pharmaceutical
Figure 16. Global Sotagliflozin Market: Pharmaceutical (2018-2023) & (Tons)
Figure 17. Sotagliflozin Consumed in Others
Figure 18. Global Sotagliflozin Market: Others (2018-2023) & (Tons)
Figure 19. Global Sotagliflozin Sales Market Share by Application (2022)
Figure 20. Global Sotagliflozin Revenue Market Share by Application in 2022
Figure 21. Sotagliflozin Sales Market by Company in 2022 (Tons)
Figure 22. Global Sotagliflozin Sales Market Share by Company in 2022
Figure 23. Sotagliflozin Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Sotagliflozin Revenue Market Share by Company in 2022
Figure 25. Global Sotagliflozin Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Sotagliflozin Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Sotagliflozin Sales 2018-2023 (Tons)
Figure 28. Americas Sotagliflozin Revenue 2018-2023 ($ Millions)
Figure 29. APAC Sotagliflozin Sales 2018-2023 (Tons)
Figure 30. APAC Sotagliflozin Revenue 2018-2023 ($ Millions)
Figure 31. Europe Sotagliflozin Sales 2018-2023 (Tons)
Figure 32. Europe Sotagliflozin Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Sotagliflozin Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Sotagliflozin Revenue 2018-2023 ($ Millions)
Figure 35. Americas Sotagliflozin Sales Market Share by Country in 2022
Figure 36. Americas Sotagliflozin Revenue Market Share by Country in 2022
Figure 37. Americas Sotagliflozin Sales Market Share by Type (2018-2023)
Figure 38. Americas Sotagliflozin Sales Market Share by Application (2018-2023)
Figure 39. United States Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Sotagliflozin Sales Market Share by Region in 2022
Figure 44. APAC Sotagliflozin Revenue Market Share by Regions in 2022
Figure 45. APAC Sotagliflozin Sales Market Share by Type (2018-2023)
Figure 46. APAC Sotagliflozin Sales Market Share by Application (2018-2023)
Figure 47. China Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Sotagliflozin Sales Market Share by Country in 2022
Figure 55. Europe Sotagliflozin Revenue Market Share by Country in 2022
Figure 56. Europe Sotagliflozin Sales Market Share by Type (2018-2023)
Figure 57. Europe Sotagliflozin Sales Market Share by Application (2018-2023)
Figure 58. Germany Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Sotagliflozin Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Sotagliflozin Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Sotagliflozin Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Sotagliflozin Sales Market Share by Application (2018-2023)
Figure 67. Egypt Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Sotagliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Sotagliflozin in 2022
Figure 73. Manufacturing Process Analysis of Sotagliflozin
Figure 74. Industry Chain Structure of Sotagliflozin
Figure 75. Channels of Distribution
Figure 76. Global Sotagliflozin Sales Market Forecast by Region (2024-2029)
Figure 77. Global Sotagliflozin Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Sotagliflozin Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Sotagliflozin Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Sotagliflozin Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Sotagliflozin Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のソタグリフロジン市場予測 2023年-2029年(Global Sotagliflozin Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のソタグリフロジン市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp